An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.

Autor: Waldock J; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom., Weiss CD; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Wang W; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Levine MZ; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Jefferson SN; Influenza Division, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA, United States., Ho S; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Hoschler K; Respiratory Viruses Unit, UK Health Security Agency, Colindale, United Kingdom., Londt BZ; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Masat E; hVivo The Queen Mary Bioenterprises (QMB) Innovation, London, United Kingdom., Carolan L; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Sánchez-Ovando S; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Fox A; World Health Organisation (WHO) Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Watanabe S; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Akimoto M; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Sato A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Kishida N; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases: Musashi-Murayama, Tokyo, Japan., Buys A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Maake L; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Fourie C; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services, Johannesburg, South Africa., Caillet C; Department of Research and Development, Sanofi, Lyon, France., Raynaud S; Department of Research and Development, Sanofi, Lyon, France., Webby RJ; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., DeBeauchamp J; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States., Cox RJ; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Lartey SL; Influenza Centre, Department of Clinical Sciences, University of Bergen, Bergen, Norway., Trombetta CM; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Marchi S; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Montomoli E; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy., Sanz-Muñoz I; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Eiros JM; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sánchez-Martínez J; National Influenza Centre of Valladolid, Instituto de Estudios de Ciencias de la Salud de Castilla y León (ICSCYL), Edificio Rondilla, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Duijsings D; Viroclinics, Clinical Virology Services, Rotterdam, Netherlands., Engelhardt OG; Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory, Potters Bar, United Kingdom.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Feb 28; Vol. 14, pp. 1129765. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).

Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study.

Autor: Thompson MG; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: isq8@cdc.gov., Levine MZ; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bino S; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Hunt DR; Abt Associates, Atlanta, GA, USA., Al-Sanouri TM; The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan., Simões EAF; Center for Global Health, Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA., Porter RM; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Biggs HM; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gresh L; Sustainable Sciences Institute, Managua, Nicaragua., Simaku A; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Khader IA; The Eastern Mediterranean Public Health Network (EMPHNET), Amman, Jordan., Tallo VL; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Meece JK; Marshfield Clinic Research Foundation, Marshfield, WI, USA., McMorrow M; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mercado ES; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Joshi S; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., DeGroote NP; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Hatibi I; Department of Epidemiology and Control of Infectious Diseases, Institute of Public Health, Tirana, Albania., Sanchez F; Hospital Infantil Manuel de Jesus Rivera, Ministry of Health, Managua, Nicaragua., Lucero MG; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Faouri S; Al Bashir Hospital, Ministry of Health, Amman, Jordan., Jefferson SN; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Maliqari N; General Pediatrics Unit, University Hospital Center 'Mother Teresa', Tirana, Albania., Balmaseda A; Laboratorio Nacional de Virologia, Centro Nacional de Diagnostico y Referencia, Ministry of Health, Managua, Nicaragua., Sanvictores D; Research Institute for Tropical Medicine, Department of Health, Muntinlupa, Philippines., Holiday C; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Sciuto C; Abt Associates, Atlanta, GA, USA., Owens Z; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Azziz-Baumgartner E; Influenza Division, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gordon A; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Publikováno v: The Lancet. Child & adolescent health [Lancet Child Adolesc Health] 2019 Nov; Vol. 3 (11), pp. 781-794. Date of Electronic Publication: 2019 Sep 03.

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.

Autor: Sun X; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Belser JA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Pulit-Penaloza JA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Creager HM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States; Emory University, Atlanta, GA 30322, United States., Guo Z; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Jefferson SN; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Liu F; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., York IA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Stevens J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Maines TR; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Jernigan DB; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Levine MZ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Tumpey TM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: TTumpey@cdc.gov.

Publikováno v: Virology [Virology] 2017 Aug; Vol. 508, pp. 164-169. Date of Electronic Publication: 2017 May 26.

A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.

Autor: Veguilla V; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., López-Gatell H; Dirección General Adjunta de Epidemiología, Secretaría de Salud, Mexico City, México., López-Martínez I; Laboratorio de Virus Respiratorios, Departamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos, Mexico City, México., Aparicio-Antonio R; Laboratorio de Virus Respiratorios, Departamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos, Mexico City, México., Barrera-Badillo G; Laboratorio de Virus Respiratorios, Departamento de Virología, Instituto de Diagnóstico y Referencia Epidemiológicos, Mexico City, México., Rojo-Medina J; Centro Nacional de la Transfusión Sanguínea, Secretaría de Salud, Mexico City, México., Gross FL; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Jefferson SN; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Katz JM; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Hernández-Ávila M; Subsecretaría de Prevención y Promoción de la Salud, Secretaría de Salud, Mexico City, México., Alpuche-Aranda CM; Dirección General Adjunta del Instituto de Diagnóstico y Referencia Epidemiológicos, Mexico City, México.

Publikováno v: PloS one [PLoS One] 2016 Mar 22; Vol. 11 (3), pp. e0150428. Date of Electronic Publication: 2016 Mar 22 (Print Publication: 2016).

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study

Autor: Waldock, Joanna, Remarque, Edmond J., Lingyi Zheng, Sammy Ho, Hoschler, Katja, Neumann, Britta, Sediri-Schön, Hanna, Trombetta, Claudia M., Montomoli, Emanuele, Marchi, Serena, Lapini, Giulia, Fan Zhou, Lartey, Sarah L., Cox, Rebecca J., Facchini, Marzia, Castrucci, Maria Rita, Friel, Damien, Ollinger, Thierry, Caillet, Catherine, Music, Nedzad

Publikováno v: Frontiers in Immunology; 5/2/2023, p1-16, 16p